Citations 1
Outcomes for FOLFIRI plus bevacizumab (BEV) or cetuximab (CET) in patients previously treated with oxaliplatin-based adjuvant therapy: A combined analysis of data from FIRE-3 and CALGB 80405.
Heinemann, Volker , Niedzwiecki, Donna , Pearline, Rachel V., Höchster, Howard S. , Goldberg, Richard M. , Innocenti, Federico , Schilsky, Richard L. , Blanke, Charles D. , Stinzing, Sebastian, O’Neil, Bert H. , Niedzwiecki, Donna , Grothey, Axel , Mayer, Robert J. , Bertagnolli, Monica M. , Venook, Alan P.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3585-3585
